UP TO $150,000,000Prospectus • February 15th, 2023
We have entered into a sales agreement with Cowen and Company, LLC, or Cowen, relating to shares of our common stock, $0.0001 par value per share, offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell from time to time shares of our common stock having an aggregate offering price of up to $150.0 million through Cowen acting as our agent.
Up to $25,000,000 AKERNA CORP. Shares of Common StockProspectus • July 23rd, 2021 • Delaware
Akerna is the leading provider of enterprise software solutions within the cannabis industry. Cannabis businesses face significant complexity due to the stringent regulations and restrictions that shift based on regional, state, and national governing bodies. As the first to market more than ten years ago, Akerna’s family of software platforms enable regulatory compliance and inventory management across the entire supply chain. When the legal cannabis market started to grow, we identified a need for organic material tracking and regulatory compliance software as a service (SaaS) solution customized specifically for the unique needs of the industry. By providing an integrated ecosystem of applications and services that enables compliance, regulation, consumer safety and taxation, Akerna is building the technology backbone of the cannabis industry. While designed specifically for the unique needs of the cannabis market, our solutions are adaptable for other industries requiring governmen
BROADWIND, INC. COMMON STOCKProspectus • August 9th, 2021
This prospectus supplement and the accompanying prospectus relate to the offering of our common stock. Before buying any shares of the common stock that we are offering, we urge you to carefully read this prospectus supplement and the accompanying prospectus, together with the information incorporated by reference as described under the headings “Where You Can Find More Information” and “Incorporation by Reference” in this prospectus supplement. These documents contain important information that you should consider when making your investment decision.
Brickell Biotech, Inc.Prospectus • March 17th, 2021
We have entered into an At Market Issuance Sales Agreement, or sales agreement, with Oppenheimer & Co. Inc. and William Blair & Company, L.L.C. (each an “Agent,” and together, the “Agents”), relating to the sale of shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the sales agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $50,000,000 from time to time through the Agents acting as our sales agents, at our discretion.
PROSPECTUSProspectus • January 28th, 2016
This prospectus relates to the Ahold ordinary shares to be issued in the merger (including the Ahold ordinary shares that will be represented by Ahold ADSs) to Delhaize shareholders and Delhaize ADS holders in exchange for their Delhaize ordinary shares and Delhaize ADSs, respectively.
